youtube_live
Q3 2026 earnings • released • EPS beat +7,77% • Revenue beat +2,95%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
US$150,37
arrow_downward
-1,99%(-3,06) 1D
6 ພ.ຈ., 15 ໂມງ 59 ນາທີ 27 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$141,83
High
US$152,60
Low
US$136,42
Mkt. cap
20,18 ຕື້
Avg. vol.
1,86 ລ້ານ
Volume
4,61 ລ້ານ
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,67
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
Open
US$141,83
High
US$152,60
Low
US$136,42
Mkt. cap
20,18 ຕື້
Avg. vol.
1,86 ລ້ານ
Volume
4,61 ລ້ານ
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,67
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
GuruFocus
·
3 ຊົ່ວໂມງກ່ອນ
Guardant Health Stocks Fall 9.49% as Cash Burn Outlook Rises Des
Investor's Business Daily
·
5 ຊົ່ວໂມງກ່ອນ
Blood-Testing Gore Continues As Natera, Guardant Report
Investing.com
·
9 ຊົ່ວໂມງກ່ອນ
Guardant Health stock reiterated at Buy by BTIG after Q3 beat
Zacks
·
20 ຊົ່ວໂມງກ່ອນ
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com